Skip to main content
. 2021 Jun 10;16:162–173. doi: 10.1016/j.ijpddr.2021.05.003

Fig. 3.

Fig. 3

Screening of BZ analogues and Albendazole thioesters: A) Change in potency for BZ analogues based on the Alb IC50 (0.16 μM). Compounds include albendazole and 7 additional albendazole thioethers. B) Structures of albendazole carbamate thioethers (methylthio-to octylthio-) C) Table of IC50 in WB AlbS and AlbR lines and their respective resistance factors. albendazole (*) corresponds to the R group -SC3H7 in the thiolether series.